Treating myopic foveoschisis

Article

Treating myopic foveoschisis

Vitreous cortex removal and internal limiting membrane (ILM) peeling could be critical in treating persistent myopic foveoschisis (MF), according to the results of a study published in the American Journal of Ophthalmology.

Kaori Sayanagi, Yasushi Ikuno and Yasuo Tano from Osaka University Medical School, Osaka, Japan, examined two highly myopic eyes of two patients with persistent MF after primary vitrectomy and gas tamponade. Both were then treated with pars plana vitrectomy, residual vitreous cortex removal, ILM peeling and long-term gas tamponade.In both cases total foveal reattachment was achieved in addition to improvements in best-corrected visual acuity.

The authors concluded that re-operation with vitreous cortex removal and ILM peeling could benefit patients with MF after their primary surgery. It also indicates that both treatments, if used in the first instance, could prevent the need for any re-operation at all.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.